Moderna says patent ruling not to affect COVID-19 vaccine development
An administrative court run by the US Patent and Trademark Office rejects Moderna's arguments to invalidate a US patent owned by Arbutus, sparking worries over its efforts to develop next-generation vaccines, including a coronavirus vaccine